Caribou Biosciences (CRBU) Interest & Investment Income (2020 - 2021)
Caribou Biosciences (CRBU) reported Interest & Investment Income of $76000.0 for Q4 2021, down 3.8% year-over-year from $79000.0 in Q4 2020, and up 245.45% quarter-over-quarter from $22000.0 in Q3 2021.
Caribou Biosciences (CRBU) Interest & Investment Income (2020 - 2021) Analysis & Trends
Caribou Biosciences (CRBU) has 2 years of Interest & Investment Income data on file, last reported at $76000.0 in Q4 2021.
- Interest & Investment Income for Q4 2021 came in at $76000.0, down 3.8% year-over-year; the trailing twelve-month figure through Dec 2021 was $223000.0 (changed N/A YoY), and the FY2021 annual result was $148000.0, down 37.29% from the prior year.
- Interest & Investment Income improved to $76000.0 in Q4 2021 per CRBU's latest filing, from $22000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $79000.0 in Q4 2020 and troughed at $4000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -14.79 Mn |
| 10 | Caribou Biosciences | 177.34 Mn | 59.72 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 76,000.00 |
| Sep 30, 2021 | 22,000.00 |
| Jun 30, 2021 | 46,000.00 |
| Dec 31, 2020 | 79,000.00 |
| Sep 30, 2020 | 4,000.00 |
| Jun 30, 2020 | 11,000.00 |